Aster Dm Healthcare vs Fortis Healthcare: Share Price, Valuation and Results Compared

Aster Dm Healthcare Limited (Asterdm) (NSE: ASTERDM) and Fortis Healthcare Ltd. (NSE: FORTIS) are both listed in the Hospitals and Healthcare Centers industry. Aster Dm Healthcare has a market capitalisation of ₹58,658 Cr and Fortis Healthcare ₹57,490 Cr, as of 9 Nov 2026. Their P/E ratios are 89.6 and 55.2 respectively. Return on equity is 10.07% for Aster Dm Healthcare and 11.01% for Fortis Healthcare. Over one year, Aster Dm Healthcare's share price is up 8.1% and Fortis Healthcare's is down 24.9%.

Aster Dm Healthcare vs Fortis Healthcare — Key Figures

MetricAster Dm HealthcareFortis Healthcare
NSE SymbolASTERDMFORTIS
BSE Code540975532843
Share Price₹733.40₹774.55
Market Cap₹58,658 Cr₹57,490 Cr
P/E Ratio89.655.2
Return on Equity10.07%11.01%
Return on Assets5.45%6.84%
Dividend Yield0.00%0.13%
Beta (1Y)0.250.48
1-Year Price Change+8.1%-24.9%
3-Month Price Change-15.4%-18.1%
52-Week Range₹519.10 – ₹891.30₹704.95 – ₹1,020.30
Latest QuarterQ2 FY27Q2 FY27
Quarterly Revenue₹2,829 Cr₹2,735 Cr
Quarterly Net Profit₹322 Cr₹320 Cr
Net Margin11.4%11.7%
EPS (Basic, Quarter)₹3.19₹4.14
Results Basisconsolidatedconsolidated
HeadquartersBengaluru, KarnatakaGurugram, Haryana

The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.

About the Companies

Aster Dm Healthcare Limited (Asterdm)

Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare services in India. It operates through Hospitals, Clinics, Wholesale Pharmacies, and Others segments. The company operates hospitals, clinic, and in-house pharmacies at the hospitals and clinics. It also offers healthcare consultancy and other services. In addition, the company operates retail pharmacies and optical outlets. Aster DM Healthcare Limited was founded in 1987 and is based in Bengaluru, India.

Fortis Healthcare Ltd.

Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company offers services in the areas of cardiac science, critical care, vascular surgery, dental science, dermatology, diabetology/endocrinology, emergency and trauma, geriatric medicine, liver transplant and hepatobiliary sciences, pain and palliative medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, and haematology areas. It also provides services in the areas of infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surg…

Frequently Asked Questions

Which is larger by market cap, Aster Dm Healthcare or Fortis Healthcare?

Aster Dm Healthcare has a market capitalisation of ₹58,658 Cr, against ₹57,490 Cr for Fortis Healthcare as of 9 Nov 2026, so the two are about the same size by market cap.

What is the P/E ratio of Aster Dm Healthcare and Fortis Healthcare?

Aster Dm Healthcare has a P/E of 89.6 and Fortis Healthcare a P/E of 55.2 as of 9 Nov 2026.

What is the return on equity of Aster Dm Healthcare and Fortis Healthcare?

Aster Dm Healthcare has a return on equity of 10.07% and Fortis Healthcare 11.01%.

How have Aster Dm Healthcare and Fortis Healthcare shares moved over one year?

Aster Dm Healthcare's share price is up 8.1% over one year and Fortis Healthcare's is down 24.9%.

What were the latest quarterly results of Aster Dm Healthcare and Fortis Healthcare?

Aster Dm Healthcare reported revenue of ₹2,829 Cr and net profit of ₹322 Cr for Q2 FY27. Fortis Healthcare reported revenue of ₹2,735 Cr and net profit of ₹320 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.

Which industry are Aster Dm Healthcare and Fortis Healthcare in?

Both are classified under Health Care Providers and Services > Health Care Facilities > Hospitals and Healthcare Centers on FinBizNet.

Is this comparison a recommendation to buy or sell Aster Dm Healthcare or Fortis Healthcare?

No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.

More Comparisons

More on FinBizNet

Data as of 9 Nov 2026. Descriptive market data only — not investment advice.